| SCHEDULE OF REVENUE RECOGNIZED |
SCHEDULE
OF REVENUE RECOGNIZED
| | |
| | |
| |
| | |
For the Years Ended | |
| | |
December 31, | |
| | |
2025 | | |
2024 | |
| Product revenue | |
$ | 300,000 | | |
$ | 300,000 | |
| Royalty revenue | |
| 59,700 | | |
| 101,000 | |
| Revenues | |
$ | 359,700 | | |
$ | 401,000 | |
|
| SCHEDULE OF INVESTMENTS HELD IN MARKETABLE SECURITIES |
The following tables summarize
the Company’s investments held in marketable securities:
SCHEDULE OF INVESTMENTS HELD IN
MARKETABLE SECURITIES
| | |
Amortized Cost | | |
Gross Unrealized Gains | | |
Gross Unrealized Losses | | |
Fair Value | |
| | |
As
of December 31, 2025 | |
| | |
Amortized
Cost | | |
Gross
Unrealized Gains | | |
Gross
Unrealized Losses | | |
Fair
Value | |
| U.S.
Treasury notes | |
$ | 1,421,503 | | |
$ | 8,177 | | |
$ | - | | |
$ | 1,429,680 | |
| U.S.
Treasury bills | |
| 6,835,589 | | |
| - | | |
| - | | |
| 6,835,589 | |
| Accrued
interest | |
| - | | |
| - | | |
| - | | |
| 12,054 | |
| Investments
held in marketable securities | |
$ | 1,421,503 | | |
$ | 8,177 | | |
$ | - | | |
$ | 1,441,734 | |
| | |
Amortized Cost | | |
Gross Unrealized Gains | | |
Gross Unrealized Losses | | |
Fair Value | |
| | |
As
of December 31, 2024 | |
| | |
Amortized
Cost | | |
Gross
Unrealized Gains | | |
Gross
Unrealized Losses | | |
Fair
Value | |
| U.S.
Treasury notes and bonds | |
$ | 3,145,071 | | |
$ | 806 | | |
$ | (4,774 | ) | |
$ | 3,141,103 | |
| U.S.
Treasury bills | |
| 6,835,589 | | |
| - | | |
| - | | |
| 6,835,589 | |
| Accrued
interest | |
| - | | |
| - | | |
| - | | |
| 208,009 | |
| Investments
held in marketable securities | |
$ | 9,980,660 | | |
$ | 806 | | |
$ | (4,774 | ) | |
$ | 10,184,701 | |
|
| SCHEDULE OF WEIGHTED AVERAGE DILUTIVE COMMON SHARES |
The
following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these
potential shares was antidilutive due to the Company’s net loss position even though the exercise or conversion price could be
less than the average market price of the common shares:
SCHEDULE
OF WEIGHTED AVERAGE DILUTIVE COMMON SHARES
| | |
For the Years Ended | |
| | |
December 31, | |
| | |
2025 | | |
2024 | |
| Stock options | |
| 5,266,600 | | |
| 3,263,467 | |
| Warrants | |
| 4,495,038 | | |
| 3,951,634 | |
| Convertible Preferred Stock | |
| 1,398,158 | | |
| 1,398,158 | |
| | |
| 11,159,796 | | |
| 8,613,259 | |
|